跳至主要内容
临床试验/NL-OMON50793
NL-OMON50793招募中不适用

A clinical imaging study using [18F]F-AraG PET to visualize Tumor infiltrating T-cell Activation in Non-small cell lung cancer - ATTAI

Vrije Universiteit Medisch Centrum0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Histologically confirmed NSCLC, a histological biopsy is mandatory.
  • 2. Patients that are resectable upfront as per multidisciplinary tumor board
  • evaluation.
  • 3. Be willing and able to provide written informed consent for the trial.
  • 4. Be above 18 years of age on day of signing informed consent.
  • 5. Have a performance status of 0-1 on the ECOG Performance Scale at screening.

排除标准

  • 1. Subjects with a condition requiring systemic treatment with either
  • corticosteroids (> 10 mg daily prednisone equivalent) or other
  • immunosuppressive medications within 14 days of screening. Inhaled or topical
  • steroids, and adrenal replacement steroid >10 mg daily prednisone
  • equivalent, are permitted in the absence of active autoimmune disease.
  • 2. Psychiatric or substance abuse disorders that would interfere with
  • cooperation with the requirements of the trial.
  • 3. Patient is pregnant or breastfeeding or expecting to conceive within the
  • projected duration of the trial, starting with the screening visit through 12
  • weeks after the last [18F]F-AraG PET scan.

研究者

相似试验